{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:40:45Z","timestamp":1765294845993,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["201640192"],"award-info":[{"award-number":["201640192"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai TCM Clinical Base","award":["ZY3-LCPT-1 to DY He"],"award-info":[{"award-number":["ZY3-LCPT-1 to DY He"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["81273979"],"award-info":[{"award-number":["81273979"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"crossref","award":["Stage Study on the Mechanism of (5r)-5-hydroxy tri"],"award-info":[{"award-number":["Stage Study on the Mechanism of (5r)-5-hydroxy tri"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"the National Institutes of Health","doi-asserted-by":"crossref","award":["NIAID UO1, 1U01AI09090 to XD.Z"],"award-info":[{"award-number":["NIAID UO1, 1U01AI09090 to XD.Z"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10067-017-3624-7","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T02:08:57Z","timestamp":1492826937000},"page":"1819-1826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study"],"prefix":"10.1007","volume":"36","author":[{"given":"Dongyi","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza M.","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Reveille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongtao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,22]]},"reference":[{"key":"3624_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun J, Bollow M, Remlinger G et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58\u201367","journal-title":"Arthritis Rheum"},{"key":"3624_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"M Bollow","year":"2000","unstructured":"Bollow M, Fischer T, Reisshauer H, Backhaus M, Sieper J, Hamm B, Braun J (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis-cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59:135\u2013140","journal-title":"Ann Rheum Dis"},{"key":"3624_CR3","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/art.21907","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel H, Kuhne M, Spiekermann S et al (2006) Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum 54:1805\u20131813","journal-title":"Arthritis Rheum"},{"key":"3624_CR4","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar2035","volume":"8","author":"H Appel","year":"2006","unstructured":"Appel H, Loddenkemper C, Grozdanovic Z et al (2006) Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 8:R143","journal-title":"Arthritis Res Ther"},{"key":"3624_CR5","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1002\/art.24024","volume":"58","author":"AN Bennett","year":"2008","unstructured":"Bennett AN, McGonagle D, O\u2019Connor P et al (2008) Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58:3413\u20133418","journal-title":"Arthritis Rheum"},{"key":"3624_CR6","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"3624_CR7","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"3624_CR8","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Van der Heijde","year":"2009","unstructured":"Van der Heijde D, Lie E, Kvien TK et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818","journal-title":"Ann Rheum Dis"},{"key":"3624_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/03009742.2014.956142","volume":"44","author":"SH Sveaas","year":"2015","unstructured":"Sveaas SH, Berg IJ, Provan SA et al (2015) Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study. Scand J Rheumatol 44:118\u2013124","journal-title":"Scand J Rheumatol"},{"key":"3624_CR10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/rheumatology\/kei046","volume":"44","author":"J Sieper","year":"2005","unstructured":"Sieper J, Baraliakos X, Listing J et al (2005) Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology 44:1525\u20131530","journal-title":"Rheumatology"},{"key":"3624_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/rheumatology\/keh008","volume":"43","author":"KB Puhakka","year":"2004","unstructured":"Puhakka KB, Jurik AG, Schiottz-Christensen B et al (2004) Magnetic resonance imaging of sacroiliitis in early seronegative spondyloarthropathy. Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) 43:234\u2013237","journal-title":"Rheumatology (Oxford)"},{"key":"3624_CR12","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1007\/s00296-011-2248-5","volume":"32","author":"S Konca","year":"2012","unstructured":"Konca S, Keskin D, C\u0131l\u0131z D, Bodur H, Sakman B (2012) Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters. Rheumatol Int 32:3765\u20133770","journal-title":"Rheumatol Int"},{"key":"3624_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","volume":"33","author":"J Gratac\u00f3s","year":"1994","unstructured":"Gratac\u00f3s J, Collado A, Filella X et al (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33:927\u2013931","journal-title":"Br J Rheumatol"},{"key":"3624_CR14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","volume":"74","author":"F Ciccia","year":"2015","unstructured":"Ciccia F, Guggino G, Rizzo A et al (2015) Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann Rheum Dis 74:1739\u20131747","journal-title":"Ann Rheum Dis"},{"key":"3624_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/art.20696","volume":"51","author":"C Yang","year":"2004","unstructured":"Yang C, Gu J, Rihl M et al (2004) Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Rheum 51:691\u2013699","journal-title":"Arthritis Rheum"},{"key":"3624_CR16","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1136\/annrheumdis-2013-203352","volume":"73","author":"X Zhou","year":"2014","unstructured":"Zhou X, Wang J, Zou H et al (2014) MICA, a gene contributing strong susceptibility to ankylosing spondylitis. Ann Rheum Dis 73:1552\u20131557","journal-title":"Ann Rheum Dis"},{"key":"3624_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","volume":"57","author":"HS Hreggvidsdottir","year":"2014","unstructured":"Hreggvidsdottir HS, Noordenbos T, Baeten DL (2014) Inflammatory pathways in spondyloarthritis. Mol Immunol 57:28\u201337","journal-title":"Mol Immunol"},{"key":"3624_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.59.6.404","volume":"59","author":"J Braun","year":"2000","unstructured":"Braun J, Sieper J (2000) Anti-TNF alpha: a new dimension in the pharmacotherapy of the spondyloarthropathies. Ann Rheum Dis 59:404\u2013407","journal-title":"Ann Rheum Dis"},{"key":"3624_CR19","first-page":"570","volume":"33","author":"C Papagoras","year":"2015","unstructured":"Papagoras C, Voulgari PV, Drosos AA (2015) Golimumab, the newest TNF-\u03b1 blocker, comes of age. Clin Exp Rheumatol 33:570\u2013577","journal-title":"Clin Exp Rheumatol"},{"key":"3624_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/annrheumdis-2014-205322","volume":"74","author":"J Callhoff","year":"2015","unstructured":"Callhoff J, Sieper J, Wei\u00df A, Zink A, Listing J (2015) Efficacy of TNF\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis 74:1241\u20131248","journal-title":"Ann Rheum Dis"},{"key":"3624_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Van der Linden","year":"1984","unstructured":"Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"3624_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.21445","volume":"53","author":"WP Maksymowych","year":"2005","unstructured":"Maksymowych WP, Inman RD, Salonen D et al (2005) Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53:703\u2013709","journal-title":"Arthritis Rheum"},{"key":"3624_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3899\/jrheum.090617","volume":"84","author":"M \u00d8stergaard","year":"2009","unstructured":"\u00d8stergaard M, Maksymowych WP, Pedersen SJ, Chiowchanwisawakit P, Lambert RG (2009) Structural lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis\u2014definitions, assessment system, and reference image set. J Rheumatol Suppl 84:18\u201334.5","journal-title":"J Rheumatol Suppl"},{"unstructured":"R Core Team (2015) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna \n                    URLhttps:\/\/www.R-project.org\/","key":"3624_CR24"},{"key":"3624_CR25","volume-title":"The elements of statistical learning. Vol. 1","author":"J Friedman","year":"2001","unstructured":"Friedman J, Hastie T, Tibshirani R (2001) The elements of statistical learning. Vol. 1. Springer, Berlin Springer series in statistics"},{"key":"3624_CR26","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3899\/jrheum.120131","volume":"39","author":"WP Maksymowych","year":"2012","unstructured":"Maksymowych WP, Lambert RG, Brown LS, Pangan AL (2012) Defining the minimally important change for the Spondylo Arthritis Research Consortium of Canada Spine and sacroiliac joint magnetic resonance imaging indices for ankylosing spondylitis. J Rheumatol 39:1666\u20131674","journal-title":"J Rheumatol"},{"key":"3624_CR27","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/art.22589","volume":"56","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Landewe R, Conner-Spady B et al (2007) Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 56:1846\u20131853","journal-title":"Arthritis Rheum"},{"key":"3624_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10067-013-2349-5","volume":"33","author":"R Almod\u00f3var","year":"2014","unstructured":"Almod\u00f3var R, R\u00edos V, Oca\u00f1a S et al (2014) Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis. Clin Rheumatol 33:237\u2013241","journal-title":"Clin Rheumatol"},{"key":"3624_CR29","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980\u2013984","journal-title":"J Rheumatol"},{"key":"3624_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"C Chen","year":"2006","unstructured":"Chen C, Lin K, Yu D et al (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology 45:414\u2013420","journal-title":"Rheumatology"},{"key":"3624_CR31","first-page":"1911","volume":"32","author":"WP Maksymowych","year":"2005","unstructured":"Maksymowych WP, Poole AR, Hiebert L et al (2005) Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. J Rheumatol 32:1911\u20131917","journal-title":"J Rheumatol"},{"key":"3624_CR32","first-page":"1753","volume":"34","author":"J Woo","year":"2007","unstructured":"Woo J, Lee H, Sung I et al (2007) Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. Rheumatology 34:1753\u20131759","journal-title":"Rheumatology"},{"key":"3624_CR33","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00296-011-1852-8","volume":"32","author":"E Soliman","year":"2012","unstructured":"Soliman E, Labib W, El Tantawi G et al (2012) Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis. Rheumatol Int 32:1711\u20131720","journal-title":"Rheumatol Int"},{"key":"3624_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10875-012-9774-0","volume":"33","author":"L Xueyi","year":"2013","unstructured":"Xueyi L, Lina C, Zhenbiao W et al (2013) Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-\u03b1 therapy. J Clin Immunol 33:151\u2013161","journal-title":"J Clin Immunol"},{"key":"3624_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/ard.2005.037465","volume":"65","author":"RJ Fran\u00e7ois","year":"2006","unstructured":"Fran\u00e7ois RJ, Neure L, Sieper J, Braun J (2006) Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 65:713\u2013720","journal-title":"Ann Rheum Dis"},{"key":"3624_CR36","doi-asserted-by":"publisher","first-page":"675108","DOI":"10.1155\/2014\/675108","volume":"2014","author":"M Schulz","year":"2014","unstructured":"Schulz M, Dotzlaw H, Neeck G (2014) Ankylosing spondylitis and rheumatoid arthritis: serum levels of TNF-\u03b1 and its soluble receptors during the course of therapy with etanercept and infliximab. Biomed Res Int 2014:675108","journal-title":"Biomed Res Int"},{"key":"3624_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.20061531","volume":"204","author":"S Nadkarni","year":"2007","unstructured":"Nadkarni S, Mauri C, Ehrenstein MR (2007) Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 204:33\u201339","journal-title":"J Exp Med"},{"key":"3624_CR38","doi-asserted-by":"publisher","first-page":"12445","DOI":"10.1073\/pnas.93.22.12445","volume":"93","author":"V Groh","year":"1996","unstructured":"Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T (1996) Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 93:12445\u201312450","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3624_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0198-8859(98)00128-1","volume":"60","author":"NW Zwirner","year":"1999","unstructured":"Zwirner NW, Dole K, Stastny P (1999) Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol 60:323\u2013330","journal-title":"Hum Immunol"},{"key":"3624_CR40","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","volume":"169","author":"HR Salih","year":"2002","unstructured":"Salih HR, Rammensee HG, Steinle A (2002) Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169:4098\u20134102","journal-title":"J Immunol"},{"key":"3624_CR41","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.1073\/pnas.0502026102","volume":"102","author":"AK Kriegeskorte","year":"2005","unstructured":"Kriegeskorte AK, Gebhardt FE, Porcellini S et al (2005) NKG2D-independent suppression of T cell proliferation by H60 and MICA. Proc Natl Acad Sci U S A 102:11805\u201311810","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3624_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1874312901409010094","volume":"9","author":"Q Wang","year":"2015","unstructured":"Wang Q, Zhou X (2015) Associations of MICA polymorphisms with inflammatory rheumatic diseases. Open Rheumatol J 9:94\u2013100","journal-title":"Open Rheumatol J"},{"key":"3624_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/85321","volume":"2","author":"V Groh","year":"2001","unstructured":"Groh V, Rhinehart R, Randolph-Habecker J et al (2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2:255\u2013260","journal-title":"Nat Immunol"},{"key":"3624_CR44","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1073\/pnas.032668099","volume":"99","author":"V Tieng","year":"2002","unstructured":"Tieng V, Le Bouguenec C, du Merle L et al (2002) Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A 99:2977\u20132982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3624_CR45","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1073\/pnas.91.14.6259","volume":"91","author":"S Bahram","year":"1994","unstructured":"Bahram S, Bresnahan M, Geraghty DE, Spies T (1994) A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 91:6259\u20136263","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3624_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer S, Groh V, Wu J et al (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727\u2013729","journal-title":"Science"},{"key":"3624_CR47","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni1350","volume":"7","author":"V Groh","year":"2006","unstructured":"Groh V, Smythe K, Dai Z, Spies T (2006) Fas ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat Immunol 7:755\u2013762","journal-title":"Nat Immunol"},{"key":"3624_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1074-7613(01)00168-6","volume":"15","author":"H Das","year":"2001","unstructured":"Das H, Groh V, Kuijl C et al (2001) MICA engagement by human Vgamma 2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 15:83\u201393","journal-title":"Immunity"},{"key":"3624_CR49","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.4049\/jimmunol.175.4.2144","volume":"175","author":"B Rincon-Orozco","year":"2005","unstructured":"Rincon-Orozco B, Kunzmann V, Wrobel P et al (2005) Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol 175:2144\u20132151","journal-title":"J Immunol"},{"key":"3624_CR50","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/eji.200324705","volume":"34","author":"P Andre","year":"2004","unstructured":"Andre P, Castriconi R, Espeli M et al (2004) Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol 34:961\u2013971","journal-title":"Eur J Immunol"},{"key":"3624_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/1874312901409010060","volume":"9","author":"C Shi","year":"2015","unstructured":"Shi C, Li H, Couturier JP et al (2015) Allele specific expression of MICA variants in human fibroblasts suggests a pathogenic mechanism. Open Rheumatol J 9:60\u201364","journal-title":"Open Rheumatol J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3624-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3624-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3624-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:48:22Z","timestamp":1589442502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3624-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,22]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3624"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3624-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2017,4,22]]},"assertion":[{"value":"10 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the ethics committee of Shanghai Guanghua Hospital, Shanghai, China. Written informed consent was obtained from all patients and controls.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This work was supported by the grants from the National Natural Science Fund of China [81273979]; Shanghai Clinical Base Construction of Traditional Chinese Medicine [ZY3-LCPT-1]; Shanghai Science and Technology Development Foundation: Stage Study on the Mechanism of (5r)-5-hydroxy triptolide on Th cell Subsets and MEKK2\/MEKK3 in Rheumatoid Arthritis; and Shanghai Municipal Health Bureau [201640192]: Research on the Mechanism of (5r)-5-hydroxy triptolide on Th cell Subsets and MEKK2\/MEKK3 in Rheumatoid Arthritis, the National Institutes of Health [NIAID UO1, 1U01AI09090 to XD.Z].","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}